These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 31729155)
81. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859 [TBL] [Abstract][Full Text] [Related]
82. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation. Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189 [TBL] [Abstract][Full Text] [Related]
83. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS Transplantation; 1999 May; 67(10):1295-300. PubMed ID: 10360580 [TBL] [Abstract][Full Text] [Related]
90. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Orosz CG; Wakely E; Bergese SD; VanBuskirk AM; Ferguson RM; Mullet D; Apseloff G; Gerber N Transplantation; 1996 Mar; 61(5):783-91. PubMed ID: 8607184 [TBL] [Abstract][Full Text] [Related]
91. Mitochondrial permeability regulates cardiac endothelial cell necroptosis and cardiac allograft rejection. Gan I; Jiang J; Lian D; Huang X; Fuhrmann B; Liu W; Haig A; Jevnikar AM; Zhang ZX Am J Transplant; 2019 Mar; 19(3):686-698. PubMed ID: 30203531 [TBL] [Abstract][Full Text] [Related]
92. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling. Johansson-Percival A; Ganss R Front Immunol; 2021; 12():674375. PubMed ID: 34122434 [TBL] [Abstract][Full Text] [Related]
94. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts. Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172 [TBL] [Abstract][Full Text] [Related]
95. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279 [TBL] [Abstract][Full Text] [Related]
96. Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. Astorri E; Bombardieri M; Gabba S; Peakman M; Pozzilli P; Pitzalis C J Immunol; 2010 Sep; 185(6):3359-68. PubMed ID: 20713891 [TBL] [Abstract][Full Text] [Related]
97. Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist. Amuchastegui S; Daniel KC; Adorini L Transplantation; 2005 Jul; 80(1):81-7. PubMed ID: 16003237 [TBL] [Abstract][Full Text] [Related]
98. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888 [TBL] [Abstract][Full Text] [Related]
99. Blockade or deficiency of PD-L1 expression in intestinal allograft accelerates graft tissue injury in mice. Matsushima H; Morita-Nakagawa M; Datta S; Pavicic PG; Hamilton TA; Abu-Elmagd K; Fujiki M; Osman M; D'Amico G; Eguchi S; Hashimoto K Am J Transplant; 2022 Mar; 22(3):955-965. PubMed ID: 34679256 [TBL] [Abstract][Full Text] [Related]